CIS Biotech Overview

  • Founded
  • 2000
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $4M
Latest Deal Amount

CIS Biotech General Information


Provider of research and development services focusing on stroke and brain attack. The company offers research and development services focused on bringing to the marketplace disease-associated biomarkers and in-vitro diagnostic (IVD) tools to provide serological assessment of stroke or brain attack.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 2701 North Decatur Road
  • Main Laboratory
  • Decatur, GA 30033
  • United States
+1 (404) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CIS Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 18-Oct-2013 $4M 00.00 Completed Generating Revenue
2. Angel (individual) 14-Jul-2010 0000 00000 Completed Generating Revenue
1. Angel (individual) 24-Jun-2008 $150K $150K Completed Generating Revenue
To view CIS Biotech’s complete valuation and funding history, request access »

CIS Biotech Executive Team (3)

Name Title Board Seat Contact Info
Robert Rhinehart President & Director
Galina Izykenova Chief Technology Officer & Board Member
To view CIS Biotech’s complete executive team members history, request access »

CIS Biotech Board Members (2)

Name Representing Role Since
Galina Izykenova CIS Biotech Chief Technology Officer & Board Member 000 0000
Svetlana Dambinova CIS Biotech Chairman 000 0000
To view CIS Biotech’s complete board members history, request access »